Skip to main content
Premium Trial:

Request an Annual Quote

InformedDNA to Provide Genetic Counseling for Cigna Members

NEW YORK (GenomeWeb News) – InformedDNA today said that it is providing genetic counseling to certain members of health plan Cigna.

St. Petersburg, Fla.-based InformedDNA is providing counseling from board-certified genetics specialists to Cigna members who are at heightened risk for breast cancer, colorectal cancer syndromes, or Long QT syndrome and are considering genetic testing. Such Cigna members will be required to undergo the counseling before having a genetic test done.

"Our approach increases access to genetics specialists who have the training to ensure that every person seeking information about their genetic makeup and health risks receives the best and most personalized information available to get the most appropriate care," InformedDNA CEO David Nixon said in a statement. "This proven model for health care utilization ensures that all Cigna customers have swift access to a board-certified genetics specialist to help them evaluate the potential impact of genetic testing on them and their family members."

Life science investment firm MPM Capital's SunStates Fund earlier this month acquired a minority stake in InformedDNA with a $3 million investment.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.